Stability testing

Ended Definitive Contract Awarded Last action

Contract number
W911QY21C0093
Awardee
Awarding agency
Obligated
$17,415,643

Award facts

Opportunity
Contract value 60% obligated
  • $17,415,642.92 Current, with exercised options
  • $29,135,827.12 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Frederick, MD 21702, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00028 $0
Other Administrative Action P00027 $0
Exercise an Option P00026 $62,706
Exercise an Option P00025 $264,402
Exercise an Option P00023 $533,201
Other Administrative Action P00022 $0
Exercise an Option P00021 $372,288
Exercise an Option P00020 $264,402
Other Administrative Action P00019 $0
Other Administrative Action P00018 $0
Exercise an Option P00017 · Performance of stability testing on RF1V drug product (DP). $1,735,944
Exercise an Option P00016 · Performance stability testing on RF1V drug product (DP). $857,905
Other Administrative Action P00015 · Performance of stability testing on RF1V drug product (DP). $0
Other Administrative Action P00014 · Administrative modification to revise slin description. $0
Exercise an Option P00013 · Exercise option subline items cdrl A002 and A004 - monthly report (option 3) $1,073,925
Exercise an Option P00012 · Exercise option period 3 for continued stability testing of BOT and PLG DP $2,074,122
Other Administrative Action P00011 · Transfer contract administration from army contracting command-aberdeen proving ground, natick (ACC-APG, natick) dodaac W911QY to ACC-APG, edgewood, dodaac… $0
Supplemental Agreement for work within scope P00010 · Extend the delivery dates at no additional cost for various stability timepoints. $0
Supplemental Agreement for work within scope P00009 · Add slin 0041AA for aliquoting of bulk drug substance material, exercise option slin 0005AB for continued stability testing, and extend the delivery dates for… $123,550
Exercise an Option P00008 · Exercise optional period 2 clins for continued stability testing. $3,195,693
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 · Vaccine stability testing $0
Supplemental Agreement for work within scope P00004 · Extend delivery dates at no additional cost to the government for ongoing stability testing $0
Supplemental Agreement for work within scope P00003 · Exercise optional slins/timepoints $450,986
Exercise an Option P00002 · Optional virus stability testing time points $558,505
Exercise an Option P00001 · Optional stability testing time points $1,633,118
Original award $2,383,159
Show all 28

About this award

The Joint Program Executive Office for Chemical and Biological Defense awarded a $29.1 million definitive contract to Dynport Vaccine Company LLC for stability testing on August 6, 2021, under firm fixed price with no set-aside.

The originating pre-solicitation, posted March 15, 2021, sought stability testing services for critical material lots of rBV A/B and rF1V vaccines, including drug product, drug substance, reference materials, and other reagents. Testing must comply with FDA guidelines with documented standard operating procedures and quality oversight. The effort involves Department of Defense controlled and ITAR-restricted technical data.

Place of performance is Frederick, Maryland. The contract's ultimate completion date is December 15, 2027. Dynport Vaccine Company LLC is a subsidiary of General Dynamics Corporation and specializes in preclinical development, clinical trials, diagnostic testing, vaccine stability evaluations, and cGMP production services supporting biopharmaceutical products targeting infectious diseases.

Subcontractors include IIT Research Institute, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies USA Inc., and Battelle Memorial Institute, all providing stability testing services under prior sub-award dates spanning February 2022 through June 2024.

Subawards

Subcontractor Amount Awarded
IIT Research Institute STABILITY TESTING services $2,433,065
KBI Biopharma Inc. STABILITY TESTING services $786,797
Fujifilm Diosynth Biotechnologies USA Inc. STABILITY TESTING services $553,800
Battelle Memorial Institute STABILITY TESTING services $1,212,337

Quick answers

Who was awarded contract W911QY21C0093?

W911QY21C0093 was awarded to Dynport Vaccine Company LLC by ACC Aberdeen Proving Ground (Army Contracting Command) on August 6, 2021.

How much is contract W911QY21C0093 worth?

The government has obligated $17,415,643 on W911QY21C0093. Its potential value, with all options, is $29,135,827.

Which agency awarded contract W911QY21C0093?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY21C0093, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911QY21C0093 competed?

The extent of competition for W911QY21C0093 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award